SINCLAIR MICHAEL sold 28.9% of their position (20K shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $274.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/6/2022ACC: 0001385508-22-000068
Director10% Owner
Since Sep 2019
-20K
Net shares
Net seller
$274.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−9.74K
Price / share
$13.88
Trade value
$135.14K
% of position
14.1%
6/2/2022
69.22K→59.48K
Common Stock
Direct
Shares
−10.26K
Price / share
$13.59
Trade value
$139.49K
% of position
17.3%
6/3/2022
59.48K→49.22K
Total
Net shares
−20K
Net value
-$274.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2022 | S · Sale | −9.74K | $13.88 | $135.14K | 14.1% | 69.22K | 59.48K |
| Common Stock Direct | 6/3/2022 | S · Sale | −10.26K | $13.59 | $139.49K | 17.3% | 59.48K | 49.22K |
| Total | −20K | -$274.62K | ||||||
Derivative Transactions0
No derivative transactions reported